Search
Search Results
-
The 980 nm diode laser treatment for non-muscle-invasive bladder tumor with en bloc technique: single-center experience
BackgroundTransurethral resection of the bladder tumor (TURBT) is one of the most established urological procedures for the treatment of the primary...
-
OncoTherad® is an immunomodulator of biological response that downregulate RANK/RANKL signaling pathway and PD-1/PD-L1 immune checkpoint in non-muscle invasive bladder cancer
IntoductionBladder cancer is the second most common urinary tract cancer. Above 70% of the occurrence of bladder cancer is superficial (pTis, pTa,...
-
The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis
ObjectivesAlthough smoking is a well-recognized causative factor of urothelial bladder cancer and accounts for 50% of cases, less is known about the...
-
LC–MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer
PurposeBladder cancer (BC) is among the most frequent malignancies worldwide. Novel non-invasive markers are needed to diagnose and stage BC with...
-
Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols
IntroductionThe combination of sequential intravesical gemcitabine and docetaxel (Gem/Doce) chemotherapy has been considered a feasible option for...
-
Preoperative CT features to predict risk stratification of non-muscle invasive bladder cancer
PurposeTo investigate whether preoperative CT features can be used to predict risk stratification of non-muscle invasive bladder cancer (NMIBC).
...
-
Device-assisted intravesical chemotherapy versus bacillus Calmette–Guerin for intermediate or high-risk non-muscle invasive bladder cancer: a systematic reviewer and meta-analysis
PurposeTo investigate the effectiveness and safety of device-assisted intravesical chemotherapy compared to Bacillus Calmette–Guerin (BCG) in the...
-
Initial experience with surrounding en bloc transurethral resection of bladder tumor and simultaneous intravesical treating for non-muscle invasive bladder cancer
PurposeThe high recurrence rate after traditional transurethral resection of bladder tumor (TURBT) remains a challenge for management of non-muscle...
-
Correlation between androgen and estrogen receptor expression and clinicopathologic features in carcinoma urinary bladder
IntroductionThe molecular map** of cancers by the Cancer Genome Atlas Project has accelerated the quest for new therapeutic targets for urinary...
-
Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage
Non-muscle-invasive bladder cancer (NMIBC) represents a significant global therapeutic challenge, particularly in the era of Bacillus Calmette–Guérin...
-
Retrospective analysis of 1470-/980-nm dual-wavelength laser en bloc resection versus transurethral resection of bladder tumor for primary non-muscle-invasive bladder cancer
To compare the safety and efficacy of en bloc resection of non-muscle-invasive bladder cancer (NMIBC) using a 1470-/980-nm dual-wavelength laser...
-
Rationale Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms
BackgroundFollow-up for non-muscle invasive bladder cancer (NMIBC) is a challenge for urologists that has not been finally resolved. The intensity of...
-
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure
PurposeTo evaluate hyperthermic intravesical chemotherapy (HIVEC) efficacy regarding 1-year disease-free survival (RFS) rate and bladder preservation...
-
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
PurposeA re-transurethral resection of the bladder (re-TURB) is a well-established approach in managing non-muscle invasive bladder cancer (NMIBC)...
-
Distant metastasis without regional progression in non-muscle invasive bladder cancer: case report and pooled analysis of literature
BackgroundNon-muscle invasive bladder cancer (NMIBC) represents the majority of bladder neoplasms. It is unusual for NMIBC metastasizing distantly...
-
BCG downregulates PD1 and PD-L1 expression in bladder cancer cells co-cultivated with peripheral blood mononuclear cells
PurposeBCG is the standard of care to treat high risk non-muscle invasive bladder cancer (NMIBC), reducing recurrence. PD-L1 is a ligand of the...
-
A 10-year renaissance of en bloc resection of bladder tumors (ERBT): Are we approaching the peak or is it back to the trough?
BackgroundThe number of studies suggesting that en bloc resection of bladder tumor (ERBT) is superior to transurethral resection of bladder tumor...
-
Role of intravoxel incoherent motion MRI in diagnosis and assessment of invasiveness of urothelial bladder carcinoma
BackgroundUrinary bladder cancer is a common malignancy. Preoperative accurate judgment of the degree of tissue invasion is crucial to determine the...
-
Adjuvant intravesical treatment in patients with intermediate and high-risk non-muscle-invasive bladder cancer with BCG versus MMC applied with COMBAT or EMDA. Results of a prospective study
BackgroundBacillus Calmette–Guerin (BCG) maintenance therapy is the standard adjuvant treatment of high- and intermediate-risk non-muscle-invasive...
-
Indikationen und Technik der Frühzystektomie
Early radical cystectomy (RC) is a therapeutic option for non-muscle invasive bladder cancer (NMIBC). The 15-year overall survival after early RC in...
